Announcements Trials

Browse Landscape

Phase

Status

Unknown 2 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 9 Carcinoma, Non-Small-Cell Lung 8 Esophageal Squamous Cell Carcinoma 7 Stomach Neoplasms 4 Recurrence 4 Neoplasm Metastasis 4 Head and Neck Neoplasms 4 Lung Neoplasms 3 Colorectal Neoplasms 3 Advanced Solid Tumors 3 Advanced Solid Tumor 3 Squamous Cell Carcinoma of Head and Neck 2 Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma 2 Esophageal Neoplasms 2 Uterine Cervical Neoplasms 1 Solid Tumors 1 Small Cell Lung Carcinoma 1 Pancreatic Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Ovarian Neoplasms 1 Nasopharyngeal Neoplasms 1 Nasopharyngeal Carcinoma 1 NSCLC 1 Multiple Pulmonary Nodules 1 Mid-low Rectal Cancer 1 Melanoma 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell, Cutaneous 1

Interventions

Sorafenib 42 Bevacizumab 16 Oxaliplatin 13 Radiosurgery 10 Gemcitabine 10 Doxorubicin 10 Capecitabine 10 Leucovorin 9 Hepatectomy 9 Fluorouracil 9 Cisplatin 9 Radiofrequency Ablation 8 Nivolumab 8 pembrolizumab 7 Drug Therapy 7 Carboplatin 7 Irinotecan 6 Cryosurgery 6 Talaporfin 5 Mitomycin 5 Everolimus 5 Erlotinib Hydrochloride 5 Electroporation 5 spartalizumab 4 Sunitinib 4 Melphalan 4 Ipilimumab 4 Epirubicin 4 Embolization, Therapeutic 4 regorafenib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Liver Neoplasms × tislelizumab × Clear all

NCT05532319 2025-12-30

FRONT-1

Guangxi Medical University

Phase 2 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡